NEW YORK Nov. 22 2016 PRNewswire Immune Pharmaceuticals NASDAQ IMNP Immune announced today that it will hold an ImmunoOncology R&D Update for investors on December 8 2016 in New York City. Immune management and several Oncology Key Opinion leaders...
↧